David Shaw’s Alpine Immune Sciences Inc ALPN Stock Holding History

David Shaw’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-428,555	Closed	-$17M	–	4945
2024 Q1	$17M	Buy	428,555 +133,013	+45%	+$3.92M	0.01%	1014
2023 Q4	$5.63M	Buy	295,542 +246,911	+508%	+$3.43M	﹤0.01%	1813
2023 Q3	$557K	Buy	+48,631	New	+$598K	﹤0.01%	3382
2016 Q4	–	Sell	-7,880	Closed	-$256K	–	3652
2016 Q3	$256K	Sell	7,880 -2,771	-26%	-$67.5K	﹤0.01%	3110
2016 Q2	$196K	Sell	10,651 -106	-1%	-$1.88K	﹤0.01%	3192
2016 Q1	$179K	Buy	10,757 +1,787	+20%	+$35.8K	﹤0.01%	3211
2015 Q4	$278K	Sell	8,970 -1,846	-17%	-$63K	﹤0.01%	3413
2015 Q3	$561K	Buy	+10,816	New	+$711K	﹤0.01%	2982

David Shaw's ALPN Position: Q2 2024 in Review

David Shaw sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 428,555 shares — an estimated $17M sold.

David Shaw first reported a position in ALPN in Q3 2015 and held it in 8 quarters. The position peaked at $17M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

David Shaw reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
David Shaw sold 428,555 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $17M.
David Shaw first reported a position in Alpine Immune Sciences Inc in Q3 2015 and held it in 8 quarters.
David Shaw's Alpine Immune Sciences Inc position peaked at $17M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on D.E. Shaw & Co's 13F filing for Q2 2024, filed 14 Aug 2024.